{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T22:18:07Z","timestamp":1784585887657,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jphs.2017.11.006","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T09:17:13Z","timestamp":1511515033000},"page":"164-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure"],"prefix":"10.1016","volume":"135","author":[{"given":"Masanori","family":"Hirose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tadokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genzo","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2017.11.006_bib1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4065\/mcp.2009.0494","article-title":"Chronic heart failure: contemporary diagnosis and management","volume":"85","author":"Ramani","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jphs.2017.11.006_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jacc.2012.01.064","article-title":"The year in heart failure","volume":"60","author":"Owens","year":"2012","journal-title":"J\u00a0Am Cell Cardiol"},{"key":"10.1016\/j.jphs.2017.11.006_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10741-012-9363-6","article-title":"Treatment for chronic heart failure in the elderly: current practice and problems","volume":"18","author":"Abete","year":"2013","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jphs.2017.11.006_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-121-5-199409010-00009","article-title":"The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart","volume":"121","author":"Katz","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jphs.2017.11.006_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jphs.2017.11.006_bib6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1056\/NEJM198709243171310","article-title":"Cardiac hypertrophy in hypertension","volume":"317","author":"Frohlich","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jphs.2017.11.006_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1161\/HYPERTENSIONAHA.110.158527","article-title":"Dipeptidyl peptidase IV inhibition alters the hemodynamic response to angiotensin-converting enzyme inhibition in humans with the metabolic syndrome","volume":"56","author":"Jackson","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jphs.2017.11.006_bib8","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.2174\/13816128113199990474","article-title":"Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection","volume":"20","author":"Avogaro","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jphs.2017.11.006_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2840-10-85","article-title":"Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure","volume":"10","author":"Yin","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jphs.2017.11.006_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1475-2840-12-154","article-title":"Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner","volume":"12","author":"Hausenloy","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jphs.2017.11.006_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0828-282X(10)70010-6","article-title":"The incretin system and cardiometabolic disease","volume":"26","author":"Szmitko","year":"2010","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jphs.2017.11.006_bib12","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCULATIONAHA.106.672451","article-title":"Stromal cell\u2013derived factor-1 alpha confers protection against myocardial ischemia\/reperfusion injury: role of the cardiac stromal cell\u2013derived factor-1 alpha\u2013CXCR4 axis","volume":"116","author":"Hu","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2017.11.006_bib13","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.112.096479","article-title":"Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions","volume":"126","author":"Shigeta","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2017.11.006_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yjmcc.2015.12.026","article-title":"DPP-4 inhibition has beneficial effects on the heart after myocardial infarction","volume":"91","author":"Kubota","year":"2016","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jphs.2017.11.006_bib15","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1073\/pnas.88.18.8277","article-title":"Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in\u00a0vivo murine model of cardiac hypertrophy","volume":"88","author":"Rockman","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jphs.2017.11.006_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.vph.2006.05.006","article-title":"Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy","volume":"45","author":"Beckles","year":"2006","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.jphs.2017.11.006_bib17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.carpath.2011.05.002","article-title":"Variable phenotype in murine transverse aortic constriction","volume":"21","author":"Mohammed","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jphs.2017.11.006_bib18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-60761-247-6_7","article-title":"Mouse surgical models in cardiovascular research","volume":"573","author":"Tarnavski","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jphs.2017.11.006_bib19","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1253\/circj.CJ-11-1114","article-title":"Effects of pitavastatin on pressure overload-induced heart failure in mice","volume":"76","author":"Kameda","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.jphs.2017.11.006_bib20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00418-008-0541-5","article-title":"Characterization od the inflammation and fibrotic response in a mouse model of cardiac pressure overload","volume":"131","author":"Xia","year":"2009","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.jphs.2017.11.006_bib21","doi-asserted-by":"crossref","first-page":"H1361","DOI":"10.1152\/ajpheart.00454.2012","article-title":"Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice","volume":"304","author":"Takahashi","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jphs.2017.11.006_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2010.08.112","article-title":"Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines","volume":"401","author":"Takasawa","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jphs.2017.11.006_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2010.08.112","article-title":"Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines","volume":"401","author":"Takasawa","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jphs.2017.11.006_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00418-008-0541-5","article-title":"Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload","volume":"131","author":"Xia","year":"2009","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.jphs.2017.11.006_bib25","doi-asserted-by":"crossref","first-page":"e54518","DOI":"10.1371\/journal.pone.0054518","article-title":"DPP4 deficiency exerts protective effect against H2O2 induced oxidative stress in isolated cardiomyocytes","volume":"8","author":"Ku","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2017.11.006_bib26","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0022-2828(03)00180-9","article-title":"3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats","volume":"35","author":"Hasegawa","year":"2003","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jphs.2017.11.006_bib27","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1291\/hypres.31.1977","article-title":"Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress","volume":"31","author":"Zhao","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jphs.2017.11.006_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCHEARTFAILURE.108.823070","article-title":"Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading","volume":"2","author":"Divakaran","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jphs.2017.11.006_bib29","first-page":"97","article-title":"Collagen and Picrosirius red Staining: a polarized light assessment of fibrillar hue and spatial distribution","volume":"22","author":"Rich","year":"2005","journal-title":"Braz J Morphol Sci"},{"key":"10.1016\/j.jphs.2017.11.006_bib30","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1161\/01.CIR.99.21.2750","article-title":"Dilated cardiomyopathy is associated with signify changes in collagen type I\/III ratio","volume":"99","author":"Pauschinger","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2017.11.006_bib31","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1073\/pnas.94.5.1852","article-title":"Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development","volume":"94","author":"Liu","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jphs.2017.11.006_bib32","doi-asserted-by":"crossref","first-page":"592760","DOI":"10.1155\/2010\/592760","article-title":"Effects of sitagliptin treatment on dysmetabolism inflammation, and oxidative stress in an animal model of type 2 diabetes","volume":"2010","author":"Ferreira","year":"2010","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.jphs.2017.11.006_bib33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/0886022X.2017.1279553","article-title":"Renoprotective effects of a dipeptidyl peptidase 4 inhibitor in a mouse model of progressive renal fibrosis","volume":"39","author":"Uchida","year":"2017","journal-title":"Ren Fail"},{"key":"10.1016\/j.jphs.2017.11.006_bib34","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"SAVOR-TIMI 53 Steering Committee and Investigators. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jphs.2017.11.006_bib35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MOL.0000000000000340","article-title":"DPP-4 inhibition: insight from the bench and recent clinical studies","volume":"27","author":"Zhong","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jphs.2017.11.006_bib36","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1161\/CIRCULATIONAHA.113.007101","article-title":"CD4+ T cell promote the transition from hypertrophy to heart failure during chronic pressure overload","volume":"27","author":"Laroumanie","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2017.11.006_bib37","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","article-title":"Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling","volume":"131","author":"Frieler","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2017.11.006_bib38","doi-asserted-by":"crossref","first-page":"368703","DOI":"10.1155\/2014\/368703","article-title":"The nonglycemic actions of dipeptideyl peptidese-4 inhibitors","volume":"2014","author":"Kim","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jphs.2017.11.006_bib39","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-07-1589","article-title":"Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition","volume":"68","author":"Dang","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jphs.2017.11.006_bib40","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.112.195115","article-title":"Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism","volume":"60","author":"Liu","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jphs.2017.11.006_bib41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/HJH.0b013e328341939d","article-title":"Dipeptidyl peptidase \u2163 inhibition attenuates blood pressure rising in young spontaneously hypertensive rats","volume":"29","author":"Pacheco","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.jphs.2017.11.006_bib42","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2337\/db15-1224","article-title":"Inhibition of dipeptidyl peptidase-4 impairs ventricular function and promotes cardiac fibrosis in high fat-fed diabetic mice","volume":"65","author":"Mulvihill","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2017.11.006_bib43","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2337\/db13-1029","article-title":"Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen","volume":"63","author":"Kanasaki","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2017.11.006_bib44","doi-asserted-by":"crossref","first-page":"F963","DOI":"10.1152\/ajprenal.00259.2012","article-title":"Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice","volume":"303","author":"Rieg","year":"2012","journal-title":"Am J Physiol Ren Physiol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861317301913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861317301913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T16:34:01Z","timestamp":1535214841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861317301913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1347861317301913"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2017.11.006","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}